Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 11, Pages e47020
Publisher
Public Library of Science (PLoS)
Online
2012-11-08
DOI
10.1371/journal.pone.0047020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of cell-free tumour DNA and RNA in patients with breast cancer and benign breast disease
- (2011) Heidi Schwarzenbach et al. Molecular BioSystems
- Tumour evolution inferred by single-cell sequencing
- (2011) Nicholas Navin et al. NATURE
- The BATTLE Trial: Personalizing Therapy for Lung Cancer
- (2011) Edward S. Kim et al. Cancer Discovery
- All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer
- (2010) F. A. W. Coumans et al. ANNALS OF ONCOLOGY
- Prognostic Value of Circulating Mutant DNA in Unresectable Metastatic Colorectal Cancer
- (2010) Benoit Lefebure et al. ANNALS OF SURGERY
- A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes
- (2010) Debora Fumagalli et al. BMC CANCER
- Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer
- (2010) Ruth E. Board et al. BREAST CANCER RESEARCH AND TREATMENT
- Potential Clinical Significance of a Plasma-Based KRAS Mutation Analysis in Patients with Advanced Non-Small Cell Lung Cancer
- (2010) S. Wang et al. CLINICAL CANCER RESEARCH
- K-ras mutational status predicts poor prognosis in unresectable pancreatic cancer
- (2010) H. Chen et al. EJSO
- Clinical Implications of the Cancer Genome
- (2010) Laura E. MacConaill et al. JOURNAL OF CLINICAL ONCOLOGY
- Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers
- (2010) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Translating cancer research into targeted therapeutics
- (2010) J. S. de Bono et al. NATURE
- Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
- (2010) Alain R. Thierry et al. NUCLEIC ACIDS RESEARCH
- Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study
- (2009) R E Board et al. BRITISH JOURNAL OF CANCER
- Prospective Validation of a Prognostic Score to Improve Patient Selection for Oncology Phase I Trials
- (2009) Hendrik-Tobias Arkenau et al. JOURNAL OF CLINICAL ONCOLOGY
- Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples
- (2009) Laura E. MacConaill et al. PLoS One
- Multiplexed Assays for Detection of Mutations in PIK3CA
- (2008) R. E. Board et al. CLINICAL CHEMISTRY
- Analysis of Mutations in DNA Isolated From Plasma and Stool of Colorectal Cancer Patients
- (2008) Frank Diehl et al. GASTROENTEROLOGY
- KRASMutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab
- (2008) Astrid Lièvre et al. JOURNAL OF CLINICAL ONCOLOGY
- Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
- (2008) Rafael G. Amado et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection of Mutations inEGFRin Circulating Lung-Cancer Cells
- (2008) Shyamala Maheswaran et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation